{"id":"W4409963174","doi":"10.1056/nejmc2501018","title":"Glofitamab with Polatuzumab Vedotin in Refractory Burkitt’s Lymphoma","year":2025,"lang":"en","type":"letter","venue":"New England Journal of Medicine","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":7,"is_retracted":false,"has_abstract":false,"ca_institutions":"University Health Network; Princess Margaret Cancer Centre","funders":"","keywords":"Refractory (planetary science); Medicine; Lymphoma; Internal medicine; Brentuximab vedotin; Oncology; Cancer research; Hodgkin lymphoma; Materials science; Metallurgy","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006432618,0.0004527572,0.0006768365,0.0005951177,0.001752469,0.0015366,0.0007483474,0.009902354,0.003515509],"category_scores_gemma":[0.003856122,0.0003222066,0.0007465727,0.0004969552,0.001067755,0.001121344,0.0006263942,0.005550491,0.001391053],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.003506358,"about_ca_system_score_gemma":0.001542753,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.003176947,"about_ca_topic_score_gemma":0.006763086,"domain_scores_codex":[0.9994599,0.000145774,0.00006731295,0.00005038273,0.0001118637,0.0001646924],"domain_scores_gemma":[0.9987347,0.0006336693,0.0001070395,0.0000389038,0.00008025225,0.0004055015],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"case_report","study_design_gemma":"case_report","study_design_scores_codex":[0.00137806,0.0003351134,0.01351215,0.0003406199,0.0001187442,0.6110738,0.0004492407,0.002325868,0.004068694,0.0090875,0.2954111,0.0618991],"study_design_scores_gemma":[0.001648451,0.001390691,0.01739174,0.0007785092,0.0001962436,0.5092452,0.0007387167,0.008888722,0.003076602,0.017611,0.4389333,0.0001008128],"study_design_candidate":"case_report","study_design_consensus":"case_report","genre_codex":"commentary","genre_gemma":"empirical","genre_scores_codex":[0.1090715,0.01864917,0.001405784,0.7682163,0.01641423,0.0001643295,0.0003367344,0.0002158044,0.08552616],"genre_scores_gemma":[0.6623675,0.007991383,0.001446866,0.2647295,0.02887189,0.0001031657,0.00030831,0.00008765333,0.03409377],"genre_candidate":"empirical","genre_consensus":null,"teacher_disagreement_score":0.009902354,"threshold_uncertainty_score":0.02544057,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.0134978890614525,"score_gpt":0.2594433103076196,"score_spread":0.2459454212461671,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}